Observational studyBreast cancer (Tokyo, Japan)2026
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC.
Tadahiko Shien et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.